|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2014
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/19530
Title: | Clinical and biological features in chronic hepatitis D |
Authors: | Jaber, Samer |
Keywords: | Chronic hepatitis Delta;treatment;antiviral |
Issue Date: | 2014 |
Publisher: | Ministry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association |
Citation: | JABER, Samer. Clinical and biological features in chronic hepatitis D. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, pp. 95-96. |
Abstract: | Introduction: Infection with hepatitis D virus (HDV) has a worldwide distribution, but areas of
high prevalence include the Mediterranean Basin, inclusively Moldova. Most of the patients have progressive deterioration of liver function and increased risk of liver cirrhosis and end-stage of liver failure.
Purpose and objectives: To evaluate clinical features, paraclinical results and laboratory peculiarities of liver function in patients with chronic hepatitis D, in comparison with chronic hepatitis B patients.
Material and methods: Thirty-six patients, twenty with chronic HDV infection, with median
age of 40.2 years, and other 16 with chronic HBV infection, with median age of 43,3 years, were
investigated consecutively.
Results: The clinical presentation of patients with chronic hepatitis D shows the predominance of
astheno-vegetative syndrome (100%), dull pain in right upper quadrant (83%), hepatomegaly (60%) and
splenomegaly (33%). In patients with HDV was found veridical pronounced cytolytic syndrome,
manifested by increase of ALT (97.55+8.5 U/l) and AST (78.83+6.2 U/l) compared with control group
(p<0.001) and patients with HBV (p<0.05), also was determined tendency towards reduction of
prothrombin and albumin compared with chronic hepatitis B. Research blood count revealed a white
blood cell (3.6+0.57 x 109/1) and platelet counts (156.8+10.2 x 109/1) decreased truthful in HDV versus
the control group (p<0.01), as well as to patients with HBV (p<0.05). In HDV patients we have detected
the presence of HBsAg, anti-HBcor and anti-HDV in all patients (100%), HBeAg - in 30% of patients,
anti-HBe - in 70%. The HDV RNA was found present in all investigated patients with chronic hepatitis
D, a low titre of HBV DNA was detected in 5 (25%) patients. Chronic hepatitis D patients had high
viral level of HDV RNA, on average of 514038 IU/ml. Most of them had a negative HBV DNA - 76%,
and just 24% had parallel HBV DNA and HDV RNA.
Conclusions: In patients with HDV infection was observed a higher frequency of clinical and
paraclinical symptoms versus HBV alone, a more evident cytolytic syndrome, leukopenia and
thrombocytopenia, (p<0.01). The majority of patients with chronic hepatitis D, have high viral level
of HDV RNA, and therefore they require antiviral treatment. |
metadata.dc.relation.ispartof: | MedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldova |
URI: | http://repository.usmf.md/handle/20.500.12710/19530 |
Appears in Collections: | MedEspera 2014
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|